Nektar Therapeutics NKTR
NASDAQ NKTR
$43.58 -3.41 (-7.26%)
At close: Oct 2, 2026 · 4:00 PM EDT

Nektar Therapeutics (NKTR) Return on Assets [ROA] (2011 - 2026)

Updated

Nektar Therapeutics (NKTR) reported Return on Assets [ROA] of -16.48% for Q2 2026, up 33.29 percentage points from -49.78% a year earlier and up 12.66 percentage points from the prior quarter.

Analysis

Nektar Therapeutics (NKTR) Return on Assets [ROA] (2011 - 2026) Analysis & Trends

For FY2025, Nektar Therapeutics posted Return on Assets [ROA] of -53.18%, down 19.28 percentage points from FY2024.

  • Return on Assets [ROA] has a five-year change of -27.90 percentage points (FY2020 to FY2025).
  • By year, Return on Assets [ROA] came in at -33.90% in FY2024 (+15.90 pp), -49.80% in FY2023 (-9.51 pp), -40.29% in FY2022 (-0.84 pp) and -39.45% in FY2021 (-14.17 pp).
  • The Q2 2026 figure ranks as the highest quarterly Return on Assets [ROA] since Q1 2019.
  • Year over year, Return on Assets [ROA] gained in five of the last eight quarters, with an average year-over-year change of +9.63 percentage points.
  • The high point for year-over-year Return on Assets [ROA] in five years was Q2 2026 (a gain of 33.29 percentage points); the low point was Q2 2022 (a drop of 22.11 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -29.14% (Q1 2026), -53.41% (Q4 2025) and -44.55% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 Nektar Therapeutics 1.44 Bn -328.37 Mn - -16.48%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -16.48%
Mar 31, 2026 -29.14%
Dec 31, 2025 -53.41%
Sep 30, 2025 -44.55%
Jun 30, 2025 -49.78%
Mar 31, 2025 -45.91%
Dec 31, 2024 -38.89%
Sep 30, 2024 -51.68%
Jun 30, 2024 -47.90%
Mar 31, 2024 -44.29%
Dec 31, 2023 -65.71%
Sep 30, 2023 -62.71%
Jun 30, 2023 -58.12%
Mar 31, 2023 -65.21%
Dec 31, 2022 -49.37%
Sep 30, 2022 -55.28%
Jun 30, 2022 -55.65%
Mar 31, 2022 -45.88%
Dec 31, 2021 -43.75%
Sep 30, 2021 -37.41%
API Access

Nektar Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=NKTR&period=max&api_key=YOUR_API_KEY